Cargando…
Rational Basis for Nutraceuticals in the Treatment of Glaucoma
BACKGROUND: Glaucoma, the second leading cause of blindness worldwide, is a chronic optic neuropathy characterized by progressive retinal ganglion cell (RGC) axons degeneration and death. Primary open-angle glaucoma (OAG), the most common type, is often associated with increased intraocular pressure...
Autores principales: | Antonio, Morrone Luigi, Laura, Rombolà, Annagrazia, Adornetto, Tiziana, Corasaniti Maria, Rossella, Russo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bentham Science Publishers
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6120110/ https://www.ncbi.nlm.nih.gov/pubmed/29119928 http://dx.doi.org/10.2174/1570159X15666171109124520 |
Ejemplares similares
-
Natural Products: Evidence for Neuroprotection to Be Exploited in Glaucoma
por: Adornetto, Annagrazia, et al.
Publicado: (2020) -
New Trends in Migraine Pharmacology: Targeting Calcitonin Gene–Related Peptide (CGRP) With Monoclonal Antibodies
por: Scuteri, Damiana, et al.
Publicado: (2019) -
The Role of Autophagy in Glaucomatous Optic Neuropathy
por: Adornetto, Annagrazia, et al.
Publicado: (2020) -
Post-ischemic treatment with azithromycin protects ganglion cells against retinal ischemia/reperfusion injury in the rat
por: Varano, Giuseppe Pasquale, et al.
Publicado: (2017) -
Anxiolytic-Like Effects of Bergamot Essential Oil Are Insensitive to Flumazenil in Rats
por: Rombolà, Laura, et al.
Publicado: (2019)